Literature DB >> 16705877

Serological profile and virological evaluation of hepatitis B and hepatitis C virus infection among HIV infected patients in Greece.

loannis S Elefsiniotis1, Vassilios Paparizos, Chrysoula Botsi, Konstantinos D Pantazis, Andreas Katsambas.   

Abstract

In this study we evaluate the prevalence of HBV and HCV infections and the HBV and/or HCV viral load as well as HCV genotype among 737 HIV-infected patients. 89/737 (12.1%) were HBsAg(+) and the majority of them (60.7%) were HBeAg(+), in contrast to general Greek population; anti-HBc seropositivity was detected in 48.1% of the study population. Serum HBV-DNA levels were 5.75 +/- 1.66 (-log 10 copies/ml) and HBeAg(+) coinfected patients had significantly higher levels than HBeAg(-) ones (7.40 +/- 0.64 vs 4.59 +/- 1.01, respectively, p < 0.001). 8.2% of HIV-infected patients were anti-HCV(+) and the majority of them (85.7%) had HCV-RNA levels more than 700.000 IU/I. The most common HCV-genotype was genotype-1 (12/28, 42.9%), representing a difficult-to-treat special population.

Entities:  

Mesh:

Year:  2006        PMID: 16705877     DOI: 10.21101/cejph.b0047

Source DB:  PubMed          Journal:  Cent Eur J Public Health        ISSN: 1210-7778            Impact factor:   1.163


  3 in total

Review 1.  Hepatocellular carcinoma, human immunodeficiency virus and viral hepatitis in the HAART era.

Authors:  Douglas C MacDonald; Mark Nelson; Mark Bower; Thomas Powles
Journal:  World J Gastroenterol       Date:  2008-03-21       Impact factor: 5.742

2.  Seroprevalence of hepatitis B virus (HBV) and hepatitis C virus (HCV) among human immunodeficiency virus (HIV)-infected patients in an HBV endemic area in Brazil.

Authors:  Claudinei Mesquita da Silva; Leyde Daiane de Peder; Alessandra Michele Guelere; Josana Dranka Horvath; Eraldo Schunk Silva; Jorge Juarez Vieira Teixeira; Dennis Armando Bertolini
Journal:  PLoS One       Date:  2018-09-07       Impact factor: 3.240

3.  Hepatitis B and C prevalence and incidence in key population groups with multiple risk factors in the EU/EEA: a systematic review.

Authors:  Lauren Mk Mason; Erika Duffell; Irene K Veldhuijzen; Uarda Petriti; Eveline M Bunge; Lara Tavoschi
Journal:  Euro Surveill       Date:  2019-07
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.